The Protocol for the Cannabidiol in Children With Refractory Epileptic Encephalopathy (CARE-E) Study: A Phase 1 Dosage Escalation Study

BMC Pediatrics - United Kingdom
doi 10.1186/s12887-018-1191-y
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Dosage Related Efficacy and Tolerability of Cannabidiol in Children With Treatment-Resistant Epileptic Encephalopathy: Preliminary Results of the CARE-E Study

Frontiers in Neurology
Neurology
2019English

Human Amnion Cells for the Prevention of Bronchopulmonary Dysplasia: A Protocol for a Phase I Dose Escalation Study

BMJ Open
Medicine
2019English

Tanespimycin Monotherapy in Relapsed Multiple Myeloma: Results of a Phase 1 Dose-Escalation Study

British Journal of Haematology
Hematology
2010English

A Phase I Clinical Trial for [131I]meta-Iodobenzylguanidine Therapy in Patients With Refractory Pheochromocytoma and Paraganglioma: A Study Protocol

Journal of Medical Investigation
BiochemistryMedicineGeneticsMolecular Biology
2017English

Epileptic Encephalopathy

Journal of Child Neurology
Child HealthNeurologyPediatricsPerinatology
2016English

Phase 1 Dose-Escalation Study of Single-Agent Veliparib in Japanese Patients With Advanced Solid Tumors

Cancer Science
Cancer ResearchMedicineOncology
2017English

A Phase II Study of Antineoplastons A10 and AS2-1 in Children With Brain Tumors. Final Report (Protocol BT-10)

Journal of Cancer Therapy
2017English

A Multicenter Phase II Study of S-1 for Gemcitabine-Refractory Biliary Tract Cancer

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2013English

A Phase 1, Open-Label, Dose Escalation Study of Intravenous Paricalcitol in Combination With Gemcitabine in Patients With Advanced Malignancies

Cancer
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy